Ocular sarcoidosis.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D002738:Chloroquine / Q000627:therapeutic use; D003231:Conjunctivitis / Q000209:etiology; D005128:Eye Diseases / Q000175:diagnosis / Q000209:etiology; D005132:Eye Manifestations; D005158:Facial Paralysis / Q000175:diagnosis; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D007731:Kveim Test; D008875:Middle Aged; D010113:Oxyphenbutazone / Q000627:therapeutic use; D010211:Papilledema / Q000209:etiology; D010309:Parotitis / Q000175:diagnosis; D012507:Sarcoidosis / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D013577:Syndrome; D014605:Uveitis / Q000209:etiology; D014606:Uveitis, Anterior / Q000209:etiology; D014608:Uveoparotid Fever / Q000453:epidemiology
D000305:Adrenal Cortex Hormones; D002738:Chloroquine; D010113:Oxyphenbutazone; D007213:Indomethacin